Skip to main content

Scopolamine Transdermal System Shortage

Last Updated: November 20, 2019
Status: Resolved

Reason for the Shortage
    • Baxter has scopolamine patches available.
    • GlaxoSmithKline states the shortage was due to increased demand.
    • Perrigo has scopolamine patches available.
Available Products
    • Transderm Scop transdermal system, Baxter, 1.5 mg (1 mg/3 days), 10 count, NDC 10019-0553-03
    • Transderm Scop transdermal system, Baxter, 1.5 mg (1 mg/3 days), 24 count, NDC 10019-0553-04
    • Transderm Scop transdermal system, GlaxoSmithKline, 1.5 mg (1 mg/3 days), 4 count, NDC 66758-0208-54
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 4 count, NDC 45802-0580-84
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 10 count, NDC 45802-0580-46
    • Scopolamine transdermal system, Perrigo, 1.3 mg (1 mg/3 days), 24 count, NDC 45802-0580-62

Updated

Updated November 20, 2019 by Rachael Freeman, PharmD, BCPS. Created July 17, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer